VAERS Explorer
Back to explore

Report #2893201

Received Apr 19, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
MD
Recovered
Unknown
Vaccinated
Apr 16, 2026
Onset
Apr 16, 2026
Days to onset
0
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PPVPNEUMO (PNEUMOVAX)MERCK & CO. INC.UNKY009239

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

No additional AE reported; Patient was administered an expired dose of PNEUMOVAX 23 on Apr 16, 2026. Product expired on Mar 15, 2026. Product had no prior temperature excursions; This spontaneous report was received from a nurse and referred to a patient of unknown age and gender. The patient's medical history, past medications, and concomitant medications were not reported. On 16-Apr-2026, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (Pneumovax 23) Solution for injection (Batch/lot number Y009239 has been verified to be a valid batch/lot number for Pneumococcal Vaccine, Polyvalent (23-valent), expiration date reported and confirmed as 15-Mar-2026; route of administration, and anatomical location were not provided) administered as prophylaxis (Expired product administered). Product had no prior temperature excursions. No further information nor additional adverse events (AEs) were reported.